Tech rally leads US stocks higher

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 66%

Business News News

Business Business Latest News,Business Business Headlines

NEW YORK: Led by tech giants, Wall Street stocks finished solidly higher on Wednesday (May 20) as investor optimism over the reopening of the ...

NEW YORK: Led by tech giants, Wall Street stocks finished solidly higher on Wednesday as investor optimism over the reopening of the economy offset worries about the hit from coronavirus shutdowns.

Stocks have had a topsy-turvy week, rallying hard on Monday, retreating on Tuesday and bouncing again Wednesday as investors weigh the latest on the coronavirus. Facebook rocketed 6.0 per cent higher after unveiling tools for retailers hit by the pandemic to create online storefronts at the social network and Instagram, while Amazon advanced 2.0 per cent as it released the online game"Crucible" as a potential rival to monster hit"Fortnite."After a terrible March, stocks have lately risen on hopes the US economy will quickly bottom out and rebound solidly.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in BUSÄ°NESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Tech rally leads US stocks higherNEW YORK (AFP) - Led by tech giants, Wall Street stocks finished solidly higher on Wednesday (May 20) as investor optimism over the reopening of the economy offset worries about the hit from coronavirus shutdowns.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Trump to tap new company to make Covid-19 drugs in the USWASHINGTON (NYTIMES) - The Trump administration will announce Tuesday (May 19) that it has signed a US$354 million (S$502 million) four-year contract with a new company in Richmond, Virginia, to manufacture generic medicines and pharmaceutical ingredients that are needed to treat Covid-19 but are now made overseas, mostly in India and China.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »